Ethicon, part of Johnson & Johnson Medical Devices Companies (JJMD), demonstrates its commitment to improving access to life-changing obesity treatment and putting the most appropriate surgical tools in surgeons hands at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic Diseases (IFSO 2018).

During the congress, Ethicon will illustrate its contribution to addressing all barriers around obesity and bariatric surgery, through continued investment in technologies, research, education, training, and awareness campaigns.

Ethicon’s activities focused on education and training

Innovation remains at the core of Ethicon’s activities focused on education and training. At IFSO, the company will present comprehensive proposals for bariatric surgeons throughout the world including:

1. A Satellite Symposium on revisional surgery

2. Meet the Expert Sessions introducing results of scientific research

3. Panel Sessions dedicated to new trends in value-based healthcare

4. Real-life or 3D interactions with high-performing products.

The company will also launch Ethicon’s Bariatric Revision Surgical Solution, a portfolio of products and solutions that help bariatric surgeons effectively manage surgery with precision, efficiency, consistency, appropriate handling and performance.

“Global congresses such as IFSO are great platforms for insightful discussions. In Dubai, we will engage with our extensive network of stakeholders on how outcomes and quality of life can be further improved for patients while delivering value at every point along the care pathway”, said Said Haddad, Ethicon Vice President for EMEA.

“We want to promote dialogue on how to solve some of the most challenging problems in healthcare, in treatment, access, ethics, and sustainable health care," said Haddad.

"We are committed to providing investment in addition to supporting the medical community with best practices and dissemination of high-quality clinical data, such as the GATEWAY study, as well as providing training materials and training courses to surgeons," said Haddad.

Over the last 20 years, Ethicon has invested significantly in the treatment of obesity and related diseases. Through a combination of enabling technologies, research, education and training, patient education, and policy initiatives, Ethicon has helped to establish bariatric surgery as the standard of care for patients with severe obesity.

Based on this legacy of leadership and collaboration, bariatric surgeons can rely on Ethicon to provide comprehensive solutions that help surgeons effectively manage the challenges of both primary surgery and revision bariatric surgery.

“The field of metabolic and bariatric surgery has evolved significantly in the last decade, with a dramatic shift in general procedures and technology. With different techniques available, there is a need for more standardization and closer monitoring of all parts of the procedure to ensure that surgeons have the right competencies and can support their patients during the entire treatment journey – before, during and after the surgery,” said Tahir Yunus, bariatric surgeon KSA.

Obesity is causing a real global health emergency of pandemic proportions, placing an unsustainable burden on individuals and healthcare systems. In 2016, more than 1.6 billion people around the world were overweight, with more than 650 million of them suffering from obesity.